Merck/Schering Zetia Has 50% Combo Use; Statin Of Choice Is Lipitor 

Prescriptions for Merck/Schering-Plough's Zetia during the drug's first six weeks on the market have been split equally between monotherapy and combination use with other cholesterol-reduction products

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet